1. Figure 5 Number of AHSCT procedures for
treatment of multiple sclerosis and treatment-related mortality
Figure 5 | Number of AHSCT procedures for treatment of multiple sclerosis and treatment-related mortality. Data as reported to the European Blood and Marrow Transplantation Society (EBMT). The overall (1995–2016) treatment-related mortality for autologous haematopoietic stem cell transplantation (AHSCT) is 2.0%. However, treatment-related mortality has decreased over time and was 0.2% during the past 5 years (2012–2016). *Data from 2016 are incomplete, and data from 2017 are not yet available.
Muraro, P. A. et al. (2017) Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
Nat. Rev. Neurol. doi: /nrneurol